NuVasive Medicare Investigation Spurs Securities Class Action

Law360, Los Angeles (August 28, 2013, 8:23 PM EDT) -- A putative class of investors in spine surgical device developer NuVasive Inc. accused the company in California federal court Wednesday of concealing problems with its Medicare and Medicaid payments, leading to a 12 percent drop in the company’s stock that cost investors at least $146 million.

The company repeatedly assured investors it was complying with federal laws about claims to Medicare and Medicaid reimbursements, the class led by Danny Popov alleges in the complaint. But the company revealed in its July 30 quarterly report that it...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Mauss v. Nuvasive, Inc. et al


Case Number

3:13-cv-02005

Court

California Southern

Nature of Suit

Securities/Commodities

Judge

Jeffrey T. Miller

Date Filed

August 28, 2013

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.